New era in precision medicine for pancreatic cancer stat : Cancer Research UK

"Without Cancer Research UK and their vision for cancer precision medicine, and the commitment of the other stakeholders, we couldn't get PRECISION Panc up and running."Dr Ian Walker, Cancer Research UK's director of clinical research, said: "This ambitious project marks a new era for pancreatic cancer. Professor Andrew Biankin, a Cancer Research UK pancreatic cancer expert at the University of Glasgow, said: "PRECISION Panc aims to transform how we treat pancreatic cancer by matching the right treatment to the right patient. "Cancer Research UK is determined to streamline research, to find the right clinical trial for all pancreatic cancer patients and to ensure laboratory discoveries have patient benefit."Read more on our blog: http://scienceblog.cancerresearchuk.org/2017/03/24/giving-pancreatic-cancer-patients-better-opportunities-to-join-clinical-trials/ Little progress has been made in outcomes for pancreatic cancer patients over the last 40 years, and we believe that PRECISION Panc will reshape how we approach treatment development. - Prof Andrew BiankinThe investment will support the PRECISION Panc* project which aims to develop personalised treatments for pancreatic cancer patients, improving the options and outcomes for a disease where survival rates have remained stubbornly low.




While survival from breast and prostate Cancer is increasing, there has been barely any improvement for patients with a lesser-known type of the disease – pancreatic cancer. A new initiative called PRECISION-Panc has now been set up – involving multiple centres across the UK, with funding from Cancer Research UK and other charities – to bring pancreatic cancer treatment in line with that of other cancers. There are various reasons why pancreatic cancer is so difficult to treat. Dr Chris Lord, Leader of the Gene Function Team here at The Institute of Cancer Research in London, is part of the programme. But there are no targeted treatments approved for pancreatic cancer.


Victoria Steven, of Cancer Research UK, said: "This ambitious project marks a new era for pancreatic cancer and puts Glasgow at the forefront of pancreatic cancer research." Menu of trialsIn Scotland, pancreatic cancer incidence rates have increased by 12% over the past 10 years. Image copyright SPLA new pancreatic cancer project has been launched to find ways to speed up scientific discovery to improve the survival rates of patients. In Scotland, about 620 people were diagnosed with pancreatic cancer 10 years ago, and this has risen to about 790 people. The trials will be led by the CRUK Clinical Trials Unit at Glasgow's Beatson West of Scotland Cancer Centre.


collected by :Lucy William

To follow all the new news about Disease !!! All you need to know about all kinds of diseases